BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29614624)

  • 1. Baicalein suppresses non small cell lung cancer cell proliferation, invasion and Notch signaling pathway.
    Su G; Chen H; Sun X
    Cancer Biomark; 2018; 22(1):13-18. PubMed ID: 29614624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137.
    Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
    Genet Test Mol Biomarkers; 2018 Jun; 22(6):333-342. PubMed ID: 29812958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
    Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
    Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
    Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
    Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baicalin, a Chinese Herbal Medicine, Inhibits the Proliferation and Migration of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells, A549 and H1299, by Activating the SIRT1/AMPK Signaling Pathway.
    You J; Cheng J; Yu B; Duan C; Peng J
    Med Sci Monit; 2018 Apr; 24():2126-2133. PubMed ID: 29632297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer.
    Zhang Y; Jin X; Wang Z; Zhang X; Liu S; Liu G
    Cancer Biomark; 2017 Dec; 21(1):89-96. PubMed ID: 29081407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NBR2 inhibits EMT progression by regulating Notch1 pathway in NSCLC.
    Gao YP; Li Y; Li HJ; Zhao B
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7950-7958. PubMed ID: 31599420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo.
    Cathcart MC; Useckaite Z; Drakeford C; Semik V; Lysaght J; Gately K; O'Byrne KJ; Pidgeon GP
    BMC Cancer; 2016 Sep; 16(1):707. PubMed ID: 27586635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nobiletin inhibited hypoxia-induced epithelial-mesenchymal transition of lung cancer cells by inactivating of Notch-1 signaling and switching on miR-200b.
    Gao XJ; Liu JW; Zhang QG; Zhang JJ; Xu HT; Liu HJ
    Pharmazie; 2015 Apr; 70(4):256-62. PubMed ID: 26012256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosthorin A inhibits non-small cell lung cancer cell growth and metastasis through repressing epithelial-mesenchymal transition via downregulating Slug.
    Ni L; Li Z; Shi X; Yao C; Sun J; Ai M; Li S; Liu Y; Xu F; Zhou Y; Li J; Qiu L
    Anticancer Drugs; 2020 Nov; 31(10):997-1003. PubMed ID: 33065690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalein suppresses the proliferation of human cervical cancer cells via Notch 1/Hes signaling pathway.
    Lian H; Hui Y; Xiaoping T; Wei T; Jiyi X; Xiaolan Y
    J Cancer Res Ther; 2019; 15(6):1216-1220. PubMed ID: 31898650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baicalein suppresses growth of non-small cell lung carcinoma by targeting MAP4K3.
    Li J; Yan L; Luo J; Tong L; Gao Y; Feng W; Wang F; Cui W; Li S; Sun Z
    Biomed Pharmacother; 2021 Jan; 133():110965. PubMed ID: 33166766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway.
    Jiang M; Wang Y; Zhang H; Ji Y; Zhao P; Sun R; Zhang C
    Thorac Cancer; 2018 May; 9(5):621-629. PubMed ID: 29575809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foxk2 inhibits non-small cell lung cancer epithelial-mesenchymal transition and proliferation through the repression of different key target genes.
    Chen S; Jiang S; Hu F; Xu Y; Wang T; Mei Q
    Oncol Rep; 2017 Apr; 37(4):2335-2347. PubMed ID: 28260088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferrerol overcomes the invasiveness of lung squamous cell carcinoma cells by regulating the expression of inducers of Epithelial Mesenchymal Transition.
    Li B; Chen P; Wang JH; Li L; Gong JL; Yao H
    Microb Pathog; 2017 Nov; 112():171-175. PubMed ID: 28943152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo.
    Xie M; He CS; Wei SH; Zhang L
    Eur J Cancer; 2013 Nov; 49(16):3559-72. PubMed ID: 23916913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L; Han S; Jiao Y; Jiang S; He X; Li P
    Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.